SamaCare, a workflow platform for suppliers providing specialty treatment, introduced it secured $17 million in an oversubscribed Collection B funding spherical.
New investor Questa Capital led the spherical with participation from current traders South Park Commons and Vive Collective.
WHAT IT DOES
The California-based firm gives a cloud-based workflow automation platform to assist suppliers receive prior authorization for specialty drug drugs, test enrollment, and confirm advantages. It additionally works with pharmaceutical firms to offer knowledge analytics to assist enhance entry to their therapies.
The corporate will use the funds to develop its Script-to-Remedy Working System, which is able to leverage AI for administrative duties, create a post-prescription workflow, gather knowledge insights and improve collaboration between suppliers’ workplaces.
“SamaCare plans to take a position the funds to construct the great Script-to-Remedy Working System, enhancing our specialty prior auth platform’s capabilities for sufferers, suppliers, and pharmaceutical firms,” Syam Palakurthy, founder and CEO of SamaCare, advised MobiHealthNews in an e mail.
“This implies constructing into our platform extra collaboration options, AI-based steering, and knowledge insights that collectively allow our prospects to make sure that sufferers overcome administrative and monetary obstacles to begin on remedy.”
MARKET SNAPSHOT
SamaCare closed a $12 million Collection A spherical in 2022.
Different firms providing workflow automation platforms embody Cerner, which was acquired by enterprise software giant Oracle in 2021 for $28.3 billion, and Epic, which gives scientific and administrative workflow instruments.
